In mucinous carcinoma of the ovary, previous studies clearly showed that the KRAS mutation was the important key point of the pathogenesis of the cancer (Lee et al., 2016; Teer et al., 2017). The gene discussed is KRAS; the disease is ovarian mucinous adenocarcinoma.